MiR423-5p As a Circulating Biomarker for Heart Failure
暂无分享,去创建一个
Perry D Moerland | Allard C van der Wal | A. Tijsen | Y. Pinto | E. Creemers | P. Moerland | L. D. de Windt | A. C. van der Wal | Esther E Creemers | Anke J Tijsen | Yigal M Pinto | W. Kok | Leon J de Windt | Wouter E Kok
[1] E. Olson,et al. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. , 2007, The Journal of clinical investigation.
[2] Y. Pinto,et al. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations. , 2008, The American journal of cardiology.
[3] Anna Velander Gisslén,et al. Reference List , 2006, Mammalian Genome.
[4] Thomas Thum,et al. MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.
[5] Edwin Cuppen,et al. Diversity of microRNAs in human and chimpanzee brain , 2006, Nature Genetics.
[6] Antoni Bayes-Genis,et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. , 2006, European heart journal.
[7] Eugene Berezikov,et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. , 2006, Genome research.
[8] G. Hirokawa,et al. Plasma miR-208 as a biomarker of myocardial injury. , 2009, Clinical chemistry.
[9] Kang Li,et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. , 2010, Biochemical and biophysical research communications.
[10] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[11] A. Moorman,et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data , 2009, Nucleic acids research.